We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Idaho Technology Becomes BioFire Diagnostics

By LabMedica International staff writers
Posted on 11 Sep 2012
Idaho Technology, Inc. More...
has changed its corporate name to BioFire Diagnostics, Inc. (Salt Lake City, UT, USA) to more accurately reflect its growing breadth of services in molecular diagnostics. The company also re-launched its website to reveal its new branding.

BioFire Diagnostics will continue to focus on its FilmArray pathogen detection system to develop multiplex diagnostic tests for various clinical applications. The FilmArray Respiratory Panel (RP) is US Food and Drug Administration (FDA; Silver Spring, MD, USA)-cleared for 20 viral and bacterial respiratory pathogens. The company now provides the only FDA-cleared clinical diagnostic test for 8 of the 20 organisms in its panel.

The company is continuing to develop a broader test menu for its FilmArray system, including a blood culture ID panel, gastrointestinal panel, and a meningitis panel. BioFire is also working on reliable and sensitive biosurveillance products such as its polymerase chain reaction (PCR)-based biodetection system RAZOR EX and the FilmArray BioSurveillance system. With over 70 patents related to polymerase chain reaction (PCR), the company has used its extensive patent portfolio to successfully market nearly 200 products to the clinical, research, and military markets.

The diagnostic respiratory panel, FilmArray RP operates on the user-friendly FilmArray system, for hospital-based clinical laboratories in the US and EU.

Kirk Ririe, CEO of BioFire Diagnostics said, "We have established strong momentum in the diagnostics marketplace and the new branding under BioFire Diagnostics better reflects the markets we serve. We believe we are in an excellent position to continue building our business by driving growth of our broad molecular diagnostic product portfolio."

BioFire collaborates with various US governmental agencies including the Department of Health and Human Services and the Department of Defense. Additionally, researchers, medical technicians, law enforcement officers, and soldiers in the field use company devices to detect or study disease-causing organisms.

Related Links:
BioFire Diagnostics, Inc.
US Food and Drug Administration


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
Whole Blood Control
Lyphochek Whole Blood Control
New
STI Test
REALQUALITY RQ-SevenSTI
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: ctDNA analysis has proved effective in monitoring tumor evolution and resistance mechanisms in real time (Photo courtesy of 123RF)

Genetic Testing and Blood-Based Monitoring Improve Understanding and Tracking of Prostate Cancer

Many men with aggressive prostate cancer face high recurrence rates despite undergoing treatment. Now, findings of a new study suggest that specific gene mutations may be key to understanding these outcomes... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: An algorithm within the Check4 platform interprets data from the cartridge and sends test results to users by text or email (Photo courtesy of IdentifySensors)

Digital Diagnostic Platform Uses Electronic Technology for Rapid Disease Detection

Traditional diagnostic methods often fall short in providing rapid, accurate detection of infectious diseases, leading to delays in treatment and increased transmission. Now, a groundbreaking digital diagnostics... Read more

Technology

view channel
Image: The second-generation sampler currently under development (Photo courtesy of Breathe BioMedical)

Breath Test to Enable Early Detection of Breast Cancer

Mammograms often fail to detect breast cancer in women with dense breast tissue, missing up to 60% of cases due to reduced image clarity. Breath analytics has the potential to allow for timely detection... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.